![Sander Slootweg](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Sander Slootweg
Vorsitzender bei
NorthSea Therapeutics BV
Profil
Sander Slootweg is currently Chairman at NorthSea Therapeutics BV, Director at Xention Ltd., Oxyrane Belgium NV, and Azafaros BV, and Managing Partner at Forbion Capital Partners Management Holding BV since 2006.
Former positions include Director roles at Pulmagen Therapeutics (Synergy) Ltd., Abiomed Europe GmbH, Fovea Pharmaceuticals SA, Argenta Ltd., uniQure NV, Pieris Pharmaceuticals, Inc., Alantos Pharmaceuticals, Inc., Forbion European Acquisition Corp., Replimune Group, Inc., and NewAmsterdam Pharma Holding BV (2020–2022), as well as Investment Director at ABN Amro Capital Life Sciences and Non-Executive Director at NewAmsterdam Pharma Co. NV.
Education includes an undergraduate degree from Nyenrode Business Universiteit (1989) and a graduate degree from Vrije Universiteit Amsterdam (1992).
Aktive Positionen von Sander Slootweg
| Unternehmen | Position | Beginn |
|---|---|---|
NorthSea Therapeutics BV
 NorthSea Therapeutics BV BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that develops novel strategies for the treatment of metabolic, inflammatory and fibrotic diseases | Vorsitzender | - |
Azafaros BV
 Azafaros BV Pharmaceuticals: MajorHealth Technology Develops therapeutic agents for the treatment of rare metabolic disorders | Direktor/Vorstandsmitglied | - |
Xention Ltd.
 Xention Ltd. Pharmaceuticals: MajorHealth Technology Develops and researches drugs | Direktor/Vorstandsmitglied | - |
Oxyrane Belgium NV | Direktor/Vorstandsmitglied | - |
Forbion Capital Partners Management Holding BV
 Forbion Capital Partners Management Holding BV Investment ManagersFinance Forbion is an active manager invest companies located in Northwest Europe and the United States. The firm focuses on companies operating in the fields of life sciences and biomedical technology. It participates in early stage capital requirements with an investment size ranging from EUR 1 - 7 million. It participates in follow-on investments, takes a board seat and acts as lead investor. | Private Equity Investor | 01.12.2006 |
Ehemalige bekannte Positionen von Sander Slootweg
| Unternehmen | Position | Ende |
|---|---|---|
| FRAZIER LIFESCIENCES ACQUISITION CORPORATION | Vorsitzender | - |
| ENGE HLDGNPV | Direktor/Vorstandsmitglied | 01.11.2023 |
NewAmsterdam Pharma Holding BV
 NewAmsterdam Pharma Holding BV BiotechnologyHealth Technology Engages in research and development of transformative therapies for cardio metabolic diseases | Direktor/Vorstandsmitglied | 01.11.2022 |
Argenta Ltd.
 Argenta Ltd. Pharmaceuticals: MajorHealth Technology Operates as an animal health contract research, development and manufacturing organization | Direktor/Vorstandsmitglied | 01.01.2010 |
| ░░░░░ ░░░░░░░░░░░░░░░ ░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Ausbildung von Sander Slootweg
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
70
Beziehungen ersten Grades
19
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 19 |
|---|---|
Nyenrode Business Universiteit
 Nyenrode Business Universiteit Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pulmagen Therapeutics (Synergy) Ltd.
 Pulmagen Therapeutics (Synergy) Ltd. Miscellaneous Commercial ServicesCommercial Services Develops therapeutics for respiratory diseases | Commercial Services |
ABIOMED Europe GmbH
 ABIOMED Europe GmbH Medical SpecialtiesHealth Technology Manufactures and markets micro blood pumps | Health Technology |
Vrije Universiteit Amsterdam
 Vrije Universiteit Amsterdam Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Fovea Pharmaceuticals SA
 Fovea Pharmaceuticals SA Pharmaceuticals: MajorHealth Technology Develops and commercializes drugs for the treatment of ocular diseases | Health Technology |
Forbion Capital Partners Management Holding BV
Forbion Capital Partners Management Holding BV Investment ManagersFinance Forbion is an active manager invest companies located in Northwest Europe and the United States. The firm focuses on companies operating in the fields of life sciences and biomedical technology. It participates in early stage capital requirements with an investment size ranging from EUR 1 - 7 million. It participates in follow-on investments, takes a board seat and acts as lead investor. | Finance |
ABN Amro Capital Life Sciences | |
Argenta Ltd.
Argenta Ltd. Pharmaceuticals: MajorHealth Technology Operates as an animal health contract research, development and manufacturing organization | Health Technology |
Xention Ltd.
Xention Ltd. Pharmaceuticals: MajorHealth Technology Develops and researches drugs | Health Technology |
uniQure NV
 uniQure NV BiotechnologyHealth Technology Engages in the discovery, development and commercialization of gene therapies products | Health Technology |
Pieris Pharmaceuticals, Inc.
 Pieris Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops and markets an anticalin-brand protein technology | Health Technology |
Replimune Group, Inc.
 Replimune Group, Inc. BiotechnologyHealth Technology Develops oncolytic immunotherapies | Health Technology |
NorthSea Therapeutics BV
NorthSea Therapeutics BV BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that develops novel strategies for the treatment of metabolic, inflammatory and fibrotic diseases | Health Technology |
Oxyrane Belgium NV | |
Azafaros BV
Azafaros BV Pharmaceuticals: MajorHealth Technology Develops therapeutic agents for the treatment of rare metabolic disorders | Health Technology |
NewAmsterdam Pharma Holding BV
NewAmsterdam Pharma Holding BV BiotechnologyHealth Technology Engages in research and development of transformative therapies for cardio metabolic diseases | Health Technology |
Alantos Pharmaceuticals, Inc. | |
Forbion European Acquisition Corp.
 Forbion European Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
NewAmsterdam Pharma Co. NV
 NewAmsterdam Pharma Co. NV Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that researches, develops, manufactures and commercializes transformative therapies for cardio-metabolic diseases | Health Technology |
